TokenPost topic

Madrigal Pharmaceuticals

1 TokenPost story is tagged Madrigal Pharmaceuticals. The newest appear first.

Latest Madrigal Pharmaceuticals stories

• Madrigal Plans MASH Cirrhosis Trial With More Than 2,000 Patients for 2027

  The planned Phase 3 MAESTRO-CSPH study is targeted to start in the first half of 2027, pending regulatory discussions. Madrigal expects results in the early 2030s.

  Nov 4, 2026, 6:36 AM EST · Business